As of Aug 28
| +0.06 / +6.38%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 50.00. The median estimate represents a +4,900.00% increase from the last price of 1.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.